This website uses cookies. Cookies are used to optimize user experience and webanalytics.

More OK

Advisory Board

Udo J. Vetter

Udo J. Vetter studied clinical pharmacy at the University of Washington in Seattle. After university, he worked for five years as a pharmacist at the pharmaceutical concern Schering-Plough Corp. (now Merck & Co Inc.), and set up production facilities in Puerto Rico. Subsequently, he was, among other things, Vice President for licensing and production at Martec Inc., and President of Vetter Pharma-Turm Inc. Since 1987, he holds various senior management positions at Vetter. Moreover, Udo J. Vetter is chairman of the board since 2008. In 2003, he established the investment company UV-Cap. Udo J. Vetter is a member of the supervisory board of Gerresheimer AG and of the expert association ISPE. Furthermore, he is chairman of the university council of the University Albstadt-Sigmaringen and since 2012 he is Vice President of European Family Businesses (EFB).

Bianca Vetter

Bianca Vetter studied marketing management and foreign languages in London and Paris. In the early 1980s, she worked for a series of German and American companies as sales or executive assistant. Afterwards, Bianca Vetter worked in Administration Management for Dornier, Nortel Dasa and NDSatcom. Since 2008 she specializes in furthering technical sports education for young people.

Dr. Ute Amann

Dr. Ute Amann studied pharmacy at the Freie University of Berlin and graduated at the Ludwig-Maximilian-University Munich as Master of Public Health. She was employed for several years as a pharmacist in Germany and New Zealand and worked as a clinical pharmacist in the hospitals of the Universities of Freiburg and Munich, at the Bavarian Association of Statutory Health Insurance Physicians, and also at a company for health care statistics. From 2010 onwards, she works as a scientist amongst others at the Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, and since 2013 at the KORA Myocardial Infarction Registry of the Helmholtz Zentrum M√ľnchen, German Research Center for Environmental Health. She is medical advisor at Vetter since 2003 and consuls the company on medical-pharmaceutical matters.

Dr. Axel Herberg

Dr. Axel Herberg is a private investor in corporate and real estate investments. From 2010-17, he was a partner with the investment firm Blackstone Group, where he is now a senior advisor. Prior to joining the Blackstone Group, Dr. Herberg spent 10 years as Chief Executive Officer of the packaging specialist Gerresheimer. In May 2015, he was elected as Chairman of the Gerresheimer Group´s Supervisory Board, having been a member since 2014. Dr. Herberg has held a number of senior management posts at Gerresheimer AG since 1992. Prior, he worked as a consultant at McKinsey & Company as well as head of strategic planning at Krupp Industrietechnik. Dr. Herberg has a Ph.D. in business administration and has completed an advanced degree in mechanical engineering. He is also a member of the Supervisory Board of Leica Camera AG.

Prof. Dr. Christof Hettich

The company and tax law expert Prof. Dr. Christof Hettich joined the Mannheim-based law firm Rittershaus in 1990. There, he specialized in the structuring of companies and was named partner within three years. Christof Hettich is, among other things, member and chairman of the supervisory boards of several listed companies. Furthermore, he is founder and managing director of Dievini Hopp Bio Tech Holding.

Wolfgang Kerkhoff

Wolfgang Kerkhoff studied business, politics and journalism in Munich and Montpellier, France. As a professional congress organizer since 1984, he organizes medically-focused events throughout Europe for firms and scientific organizations. In 1995, Wolfgang Kerkhoff was the first German to be certified as a congress organizer by the worldwide association MPI. From 1990, he headed up Eurokongress as a managing partner. He is senior partner there since 2012. Wolfgang Kerkhoff is also a member of the board of the Munich Congress Alliance and President of Asconet International.

Friedbert Klefenz

Friedbert Klefenz earned diplomas in mechanical engineering and business administration prior to beginning his career in 1981 as a project manager at Siemens/KWU. Between 1986 and 1998, he held various management positions for Pharmaplan/Pharmatec (Fresenius Group) including managing director. After moving to Bosch Packaging Technology he worked as a division head before holding the chairmanship of the divisional board of directors from 2002 to 2016. Since 2017, Friedbert Klefenz has been advising industrial companies and is also a member of several committees, advisory and supervisory boards including Valicare GmbH, Illig Maschinenbau GmbH & Co. KG, and Balluff AG.

Gert Moelgaard

With a background as a process automation engineer, Gert Moelgaard has been working in Novo Nordisk and Novo Nordisk Engineering from 1982 to 2016. He has held different senior management positions including Corporate Vice President for Pharmaceutical Engineering, Consulting and Strategic Development in NNE Pharmaplan A/S. Since 2016 he is working as independent senior consultant in Moelgaard Consulting. Gert Moelgaard has been a member or leader of several international committees and expert associations, including ISPE, PDA, ISA and other.

Gunther Strothe

Gunther Strothe graduated as MA in Economics and MBA in Freiburg/Br. and Fontainebleau, respectively. From 1976 through 1990 he worked in Germany and the USA as accountant qualified in both countries for international Accounting Firms. This was followed by managerial functions as CFO at Hugo Boss AG, Investment Banker at Goldman Sachs & Co and until 2006 Managing Director for Germany with the international Consulting Firm Oliver Wyman & Company. Since 1996 he has been a non executive member of several boards of companies.